ABELSON; Mark Barry

Patent Applications and Registrations

Patent applications and USPTO patent grants for ABELSON; Mark Barry.The latest application filed is for "ophthalmic formulations of cetirizine and methods of use".

Company Profile

3.9.16

ABELSON; Mark Barry - Andover MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20210290617 - ABELSON; Mark Barry ; et al.	2021-09-23
Compositions For The Treatment And Prevention Of Eyelid Swelling App 20210177807 - CHAPIN; Matthew Jonathan ; et al.	2021-06-17
Ophthalmic formulations of cetirizine and methods of use Grant 10,987,352 - Abelson , et al. April 27, 2	2021-04-27
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20200405711 - ABELSON; Mark Barry ; et al.	2020-12-31
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20200297719 - ABELSON; Mark Barry ; et al.	2020-09-24
Ophthalmic formulations of cetirizine and methods of use Grant 10,675,279 - Abelson , et al.	2020-06-09
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20180280383 - ABELSON; Mark Barry ; et al.	2018-10-04
Ophthalmic formulations of cetirizine and methods of use Grant 9,993,471 - Abelson , et al. June 12, 2	2018-06-12
Ophthalmic formulations of cetirizine and methods of use Grant 9,750,684 - Abelson , et al. September 5, 2	2017-09-05
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20170182035 - Abelson; Mark Barry ; et al.	2017-06-29
Compositions For The Treatment And Prevention Of Eyelid Swelling App 20170079957 - Chapin; Matthew Jonathan ; et al.	2017-03-23
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20160106666 - Abelson; Mark Barry ; et al.	2016-04-21
Compositions For The Treatment And Prevention Of Eyelid Swelling App 20140364475 - CHAPIN; Matthew Jonathan ; et al.	2014-12-11
Ophthalmic formulations of cetirizine and methods of use Grant 8,829,005 - Abelson , et al. September 9, 2	2014-09-09
Compositions for the Treatment and Prevention of Eyelid Swelling App 20140161903 - Chapin; Matthew J. ; et al.	2014-06-12
Method for the treatment and prevention of eyelid swelling Grant 8,685,439 - Chapin , et al. April 1, 2	2014-04-01
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20140045803 - Abelson; Mark Barry ; et al.	2014-02-13
Ophthalmic formulations of cetirizine and methods of use Grant 8,569,273 - Abelson , et al. October 29, 2	2013-10-29
Ophthalmic Formulations of Cetirizine and Methods of Use App 20130252971 - Abelson; Mark Barry ; et al.	2013-09-26
Compositions For The Treatment And Prevention Of Eyelid Swelling App 20120021072 - Chapin; Matthew Jonathan ; et al.	2012-01-26
Ophthalmic Formulations Of Fluticasone And Methods Of Use App 20110105450 - Chapin; Matthew J. ; et al.	2011-05-05
Compositions for the Treatment and Prevention of Eyelid Swelling App 20090136598 - Chapin; Matthew Jonathan ; et al.	2009-05-28
Compositions for the treatment and prevention of eyelid swelling App 20070264318 - Chapin; Matthew Jonathan ; et al.	2007-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.